- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00431730
Is There a Difference in Flicker Induced Vasodilatation Between Smokers and Non-Smokers?
Habitual smoking is associated with an increased risk of coronary artery disease, cerebral and peripheral vascular disease, including ocular diseases like age-related macular degeneration or diabetic retinopathy. Data of a recent study performed in the investigators lab revealed abnormal choroidal blood flow regulation in chronic smokers as compared to age-matched non-smoking subjects during isometric exercise. However, no information is yet available about the regulation of retinal vascular tone in habitual smokers.
Thus, in the current study, the investigators set out to investigate whether the regulation of retinal vessels diameters is affected in habitual smokers. It has been shown in several reports that stimulation with diffuse luminance flicker, increases retinal arterial and venous diameters, indicating for the ability of the retina to adapt to changing metabolic demands. In the current study we use this effect as a tool to investigate whether the flicker induced vasodilatation is affected in habitual smokers. This would indicate for an impaired vascular regulation process in smokers.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vienna, Austria, 1090
- Department of Clinical Pharmacology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 24 subjects aged between 18 and 35 years, nonsmokers (since at least 2 years)
- 24 subjects aged between 18 and 35 years, smokers (at least 10 cigarettes/day since 2 years)
- Body mass index between 15th and 85th percentile
- Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically irrelevant
- Normal laboratory values unless the investigator considers an abnormality to be clinically irrelevant
- Normal ophthalmic findings, ametropy < 3 dpt.
Exclusion Criteria:
- Regular use of medication, abuse of alcoholic beverages, participation in a clinical trial in the 3 weeks preceding the study
- Treatment in the previous 3 weeks with any drug
- Symptoms of a clinically relevant illness in the 3 weeks before the first study day
- History or presence of gastrointestinal, liver or kidney disease, or other conditions known to interfere with distribution, metabolism or excretion of study drugs
- Blood donation during the previous 3 weeks
- Ametropy >= 3 dpt
Study Plan
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Flicker response (Retinal vessel analyzer, Laser Doppler Velocimetry)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- OPHT-121203
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ocular Physiology
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Nidek Co. LTD.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Medical University of ViennaWithdrawn
-
Medical University of ViennaCompletedOcular Physiology | MicrocirculationAustria
-
Medical University of ViennaWithdrawnIntraocular Pressure | Ocular PhysiologyAustria
-
Medical University of ViennaCompletedOcular Physiology | Regional Blood FlowAustria
-
Medical University of ViennaCompletedOcular Physiology | Regional Blood FlowAustria
Clinical Trials on flicker light stimulation
-
Medical University of ViennaCompletedHypertension | Diabetes Mellitus, Type 1 | Hypercholesterolemia | Regional Blood FlowAustria
-
Emory UniversityGeorgia Institute of TechnologyCompletedAlzheimer DiseaseUnited States
-
Universidad de ValparaisoComisión Nacional de Investigación Científica y TecnológicaUnknownOpen Angle GlaucomaChile
-
University of LiegeUnknown
-
The First Affiliated Hospital of Shanxi Medical...Shanxi Medical UniversityCompletedSleep Quality | Sleep Duration | Sleep Onset LatencyChina
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of North Carolina, Chapel HillNot yet recruitingChronic Pain | Chronic Low-back Pain | FibromyalgiaUnited States
-
Medical University of ViennaRecruitingPrimary Open-angle Glaucoma | Macular Degeneration, DryAustria
-
University Hospital, ToulouseCompleted
-
University of Texas at AustinNot yet recruitingAutism Spectrum Disorder